Package 13668-453-30

Brand: anagrelide

Generic: anagrelide
NDC Package

Package Facts

Identity

Package NDC 13668-453-30
Digits Only 1366845330
Product NDC 13668-453
Product ID 13668-453_a049d02a-22e1-4ea2-8c05-50b50cef4362
Description

30 CAPSULE in 1 BOTTLE (13668-453-30)

Marketing

Marketing Status
Marketed Since 2017-06-30
Brand anagrelide
Generic anagrelide
Sample Package No

Linked Drug Pages (1)

anagrelide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a049d02a-22e1-4ea2-8c05-50b50cef4362", "openfda": {"upc": ["0313668453300", "0313668462302"], "unii": ["VNS4435G39"], "rxcui": ["597850", "597852"], "spl_set_id": ["875cc32a-219c-4b6b-802a-98a47cbc9a78"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (13668-453-01)", "package_ndc": "13668-453-01", "marketing_start_date": "20170630"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (13668-453-30)", "package_ndc": "13668-453-30", "marketing_start_date": "20170630"}], "brand_name": "anagrelide", "product_id": "13668-453_a049d02a-22e1-4ea2-8c05-50b50cef4362", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Platelet Production [PE]", "Phosphodiesterase 3 Inhibitors [MoA]", "Platelet-reducing Agent [EPC]"], "product_ndc": "13668-453", "generic_name": "anagrelide", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "anagrelide", "active_ingredients": [{"name": "ANAGRELIDE HYDROCHLORIDE ANHYDROUS", "strength": ".5 mg/1"}], "application_number": "ANDA209151", "marketing_category": "ANDA", "marketing_start_date": "20170630", "listing_expiration_date": "20261231"}